MAP2K7 and cancer: These mutations lead to constitutive activation of the mitogen-activated protein kinase (MAPK) cascade, which includes sequential activation of MEK and ERK enzymes, with the latter being directly involved in the changes that stimulate proliferation, survival, invasion, immune evasion, and enhanced metabolism in cancer cells.